Circulating tumour cells in blood up death risk in early-stage breast cancer patients
December 11th, 2010 - 2:47 pm ICT by ANIWashington, Dec 11 (ANI): A new study has shown that the presence of one to four circulating tumour cells in the blood of patients, who are in the early stages of breast cancer, can double the risk of cancer relapse and death.
Additionally, five or more CTCs increased recurrence by 400 percent and death by 300 percent, according to the study.
Brigitte Rack, head of the department of gynaecological oncology at the Women’s Hospital at the University of Munich, Germany, said, “The CTCs might have been released from the primary tumour before these patients underwent surgery, and the expression of stem cell markers on disseminated tumours cells has been shown by several groups.”
Rack added that these cells are cancer stem cells.
According to the study results, 21.5 percent of patients had one or more CTC in their blood before the start of adjuvant treatment. Breast cancer recurred in 114 patients, and 66 patients died.
Patients with one to four CTCs had an 88 percent increased risk of early breast cancer recurrence and a 91 percent increased risk of death from breast cancer, according to Rack.
“Our study suggests testing CTCs may prove to be important to help individualize therapy for early-stage breast cancer where no measurable tumour is present,” she said.
“Patients who seem to be at high risk due to CTC may benefit from additional treatment options, and those that don’t have CTCs may be spared side effects of some treatments.”
However, Rack cautioned that additional trials are required in order to to show an improvement of survival based on CTC diagnostics.
Results of this study were presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12, 2010. (ANI)
- More alcohol ups risk of breast cancer recurrence - Dec 14, 2009
- Novel imaging technique may cut lymphedema in breast cancer patients - Dec 12, 2010
- Treatment of pregnant breast cancer patients shouldn't be delayed - Dec 13, 2010
- Simple fingertip test may identify breast cancer patients at CTS risk - Dec 11, 2010
- Estrogen alone can cut risk of breast cancer - Dec 10, 2010
- New imaging technique may reduce lymphedema in breast cancer patients - Dec 13, 2010
- Alcohol intake after breast cancer diagnosis may increase recurrence risk - Sep 16, 2010
- Low-carb diets better for easing weight: Study - Dec 13, 2011
- Intestinal stem cells offer clues to colon cancer origin and relapse - Mar 18, 2011
- Soy food safe for breast cancer survivors - Apr 06, 2011
- Breast cancer survivors are at higher risk for hip fractures - Feb 03, 2011
- Smoking ups death risk due to breast cancer - Nov 09, 2010
- New standard treatment for breast cancer at early stages established - Dec 04, 2010
- Breast cancer drug may reduce risk of death from lung cancer - Dec 12, 2009
- Gene signature may help spot patients at colon cancer recurrence risk - Feb 27, 2010
Tags: antonio breast cancer symposium, breast cancer, breast cancer patients, breast cancer recurrence, breast cancer symposium, cancer relapse, cell markers, ctrc, death risk, high risk, munich germany, s hospital, san antonio breast, san antonio breast cancer, san antonio breast cancer symposium, stage breast cancer, stages of breast cancer, stem cells, tumour cells, university of munich